BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12682633)

  • 1. Upregulation of galectin-7 in murine lymphoma cells is associated with progression toward an aggressive phenotype.
    Moisan S; Demers M; Mercier J; Magnaldo T; Potworowski EF; St-Pierre Y
    Leukemia; 2003 Apr; 17(4):751-9. PubMed ID: 12682633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel function for galectin-7: promoting tumorigenesis by up-regulating MMP-9 gene expression.
    Demers M; Magnaldo T; St-Pierre Y
    Cancer Res; 2005 Jun; 65(12):5205-10. PubMed ID: 15958565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model.
    Oates AJ; Barraclough R; Rudland PS
    Oncogene; 1996 Jul; 13(1):97-104. PubMed ID: 8700559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-7 in lymphoma: elevated expression in human lymphoid malignancies and decreased lymphoma dissemination by antisense strategies in experimental model.
    Demers M; Biron-Pain K; Hébert J; Lamarre A; Magnaldo T; St-Pierre Y
    Cancer Res; 2007 Mar; 67(6):2824-9. PubMed ID: 17363605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of novel complementary DNA clones from T lymphoma cells: one encodes a putative multiple membrane-spanning protein.
    MacLeod CL; Fong AM; Seal BS; Walls L; Wilkinson MF
    Cell Growth Differ; 1990 Jun; 1(6):271-9. PubMed ID: 1980600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression.
    Grotzer MA; Eggert A; Zuzak TJ; Janss AJ; Marwaha S; Wiewrodt BR; Ikegaki N; Brodeur GM; Phillips PC
    Oncogene; 2000 Sep; 19(40):4604-10. PubMed ID: 11030149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent alteration of CDKN2 (p16(INK4A)/MTS1) expression in human primary prostate carcinomas.
    Chi SG; deVere White RW; Muenzer JT; Gumerlock PH
    Clin Cancer Res; 1997 Oct; 3(10):1889-97. PubMed ID: 9815578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diminished expression of S100A2, a putative tumor suppressor, at early stage of human lung carcinogenesis.
    Feng G; Xu X; Youssef EM; Lotan R
    Cancer Res; 2001 Nov; 61(21):7999-8004. PubMed ID: 11691825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance of ICAM-1-deficient mice to metastasis overcome by increased aggressiveness of lymphoma cells.
    Lalancette M; Aoudjit F; Potworowski EF; St-Pierre Y
    Blood; 2000 Jan; 95(1):314-9. PubMed ID: 10607718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancer.
    Yoshimura A; Gemma A; Hosoya Y; Komaki E; Hosomi Y; Okano T; Takenaka K; Matuda K; Seike M; Uematsu K; Hibino S; Shibuya M; Yamada T; Hirohashi S; Kudoh S
    Genes Chromosomes Cancer; 2003 Jun; 37(2):159-64. PubMed ID: 12696064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological and molecular characterization of an aggressive murine lymphoma variant: modulation in vitro and in vivo.
    Jurianz K; von Hoegen P; Schirrmacher V
    Int J Oncol; 1999 Jul; 15(1):71-9. PubMed ID: 10375596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies.
    Gallagher WM; Bergin OE; Rafferty M; Kelly ZD; Nolan IM; Fox EJ; Culhane AC; McArdle L; Fraga MF; Hughes L; Currid CA; O'Mahony F; Byrne A; Murphy AA; Moss C; McDonnell S; Stallings RL; Plumb JA; Esteller M; Brown R; Dervan PA; Easty DJ
    Carcinogenesis; 2005 Nov; 26(11):1856-67. PubMed ID: 15958521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNMT3A and DNMT3B mediate autocrine hGH repression of plakoglobin gene transcription and consequent phenotypic conversion of mammary carcinoma cells.
    Shafiei F; Rahnama F; Pawella L; Mitchell MD; Gluckman PD; Lobie PE
    Oncogene; 2008 Apr; 27(18):2602-12. PubMed ID: 17998942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triggering of T-cell leukemia and dissemination of T-cell lymphoma in MMP-9-deficient mice.
    Roy JS; Van Themsche C; Demers M; Opdenakker G; Arnold B; St-Pierre Y
    Leukemia; 2007 Dec; 21(12):2506-11. PubMed ID: 17805326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
    Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
    Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
    Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB
    Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD44 isoforms in human breast carcinoma xenografts is not influenced by the treatment of mice with cytostatics or (anti-)hormones.
    Dehmel A; Becker M; Lemm M; Fichtner I
    Anticancer Res; 1999; 19(3A):1977-87. PubMed ID: 10470143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines.
    Sigala S; Faraoni I; Botticini D; Paez-Pereda M; Missale C; Bonmassar E; Spano P
    Clin Cancer Res; 1999 May; 5(5):1211-8. PubMed ID: 10353759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between growth control, neoplastic potential and endogenous connexin43 expression in HeLa cell lines: implications for tumor progression.
    King TJ; Fukushima LH; Donlon TA; Hieber AD; Shimabukuro KA; Bertram JS
    Carcinogenesis; 2000 Feb; 21(2):311-5. PubMed ID: 10657974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells.
    Kim TY; Jong HS; Song SH; Dimtchev A; Jeong SJ; Lee JW; Kim TY; Kim NK; Jung M; Bang YJ
    Oncogene; 2003 Jun; 22(25):3943-51. PubMed ID: 12813468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.